Advertisement

DeCODE Genetics Inc & ARUP Laboratories Company Profile

01:57 EDT 19th May 2013 | BioPortfolio

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and an enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 2,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(R). For more information please visit www.aruplab.com


News Articles [ 981 Associated News Articles listed on BioPortfolio]

Amgen acquires deCODE genetics for $415 million in cash

Amgen and deCODE Genetics have entered into a definitive agreement under which Amgen will acquire deCODE Genetics. The all-cash transaction values deCODE Genetics at $415 million. For further deal inf...

Amgen, deCODE Genetics Merge to Identify and Validate Disease Targets in Human Populations

THOUSAND OAKS, Calif. and REYKJAVIK, Iceland—Amgen and deCODE Genetics announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global...

Amgen signs definitive agreement to acquire deCODE Genetics

Amgen and deCODE Genetics today announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global leader in human genetics, headquartered i...

Amgen to acquire deCODE Genetics

Amgen and deCODE Genetics announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics...

Amgen - Acquisition Of DeCODE Genetics Sends Shares To All Time Highs

By Robert Broens: Shares of Amgen (AMGN) rose some 1.6% in Monday's trading session. The biotechnology company announced the acquisition of deCODE Genetics in a deal valuing the company from Iceland a...

Amgen buying deCODE Genetics for $415 million

Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics...

News Summary: Amgen nabs deCODE Genetics for $415M

AMGEN DEAL: Biotech pioneer Amgen will pay $415 million for Iceland's deCODE Genetics, a leader in using genetic information to find disease risk factors and treatment targets.THE RATIONALE: Amgen, th...

[Amgen] buys [deCODE genetics] for $415mm in cash

[Amgen Inc.] has acquired closely held human genetics firm [deCODE genetics EHF] for $415mm in cash. DeCODE was formed in 1996 and brought in about $18mm through venture rounds before it went public...

PubMed Articles [ 401 Associated PubMed Articles listed on BioPortfolio]

Commentary.

A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry.

Lamotrigine is an anti-epileptic drug used as adjunct therapy for seizures. Lamotrigine is commonly used in pregnant women with epilepsy, a population in which therapeutic drug monitoring (TDM) is use...

Bar Codes May Have Poorer Error Rates Than Commonly Believed.

Genome-sequencing anniversary. An anniversary party.

Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism.

The purpose of this study is investigate the effects of variants in the apolipoprotein(a) gene (LPA) on vascular diseases with different atherosclerotic and thrombotic components.

Clinical Trials [ 348 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

The results from the DECODE Study have shown that postprandial (1 - 2 hours after a meal) hyperglycemia (elevated blood sugar) is more common in elderly people with diabetes than younger p...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information...

Heritage Study--Genetics, Exercise and Risk Factors

To document the role of the genotype in the cardiovascular and metabolic responses to aerobic exercise-training and the contribution of inherited factors in the changes brought about by re...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [ 846 Associated Companies listed on BioPortfolio]

DeCODE Genetics Inc & ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and an enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 2,000 tests and tes...

ARUP Laboratories and deCODE genetics

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and an enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,...

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

deCode

Based in Reykjavik, Iceland, deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. The company operates one of the most technological...

Arup

Arup is a challenging and diverse organisation. We are always looking for gifted, motivated individuals for technical, consulting, and business management roles in all parts of the firm, in all parts...

More Information about "DeCODE Genetics Inc & ARUP Laboratories" on BioPortfolio

We have published hundreds of DeCODE Genetics Inc & ARUP Laboratories news stories on BioPortfolio along with dozens of DeCODE Genetics Inc & ARUP Laboratories Clinical Trials and PubMed Articles about DeCODE Genetics Inc & ARUP Laboratories for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DeCODE Genetics Inc & ARUP Laboratories Companies in our database. You can also find out about relevant DeCODE Genetics Inc & ARUP Laboratories Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement